Michael Foote

15PUBLICATIONS
154CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 21, 2026
Molecular lineages of sporadic mismatch-repair deficient colorectal cancer.

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Oct 30, 2025
Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.

Celine Yeh, Oliver Artz, Haochen Zhang

|Sep 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.

Wungki Park, Catherine O'Connor, Joanne Chou

|Nov 19, 2024
Analysis of Shared Variants between Cancer Biospecimens.

Michael B Foote, James Robert White, Walid K Chatila

|Aug 09, 2024
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors.

Paul Johannet, Somer Abdelfattah, Callahan Wilde

Pageof 3

Frequent Collaborators

9 joint publications

Benoit Rousseau

8 joint publications

Luis A Diaz

7 joint publications

Henry Walch

7 joint publications

Andrea Cercek